Catheter Precision, Inc. Stock Split Ratio
Catheter Precision, Inc. (VTAK) reported Stock Split Ratio of 4.00% for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-17.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2021-03-17
- Catheter Precision, Inc. stockholders' equity note, stock split, conversion ratio for fiscal 2020 was 4.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|
| 2020-12-31 | 4.00% 10-K · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |